Literature DB >> 19236800

Blood purification therapy in treatment of acute renal failure in infants with melamine-induced stones.

Ying Shen1, Xiao-rong Liu, Gui-ju Zhang, Nan Zhou.   

Abstract

BACKGROUND: In 2008, infants in some areas of China suffered from stones of the urinary system which were caused by melamine-contaminated milk formula. Most of the infants were asymptomatic, and a few suffered from acute renal failure induced by urinary obstruction by stones. This study aimed to assess the significance of blood purification therapy in treatment of infants with acute obstructive oligo-anuric renal failure. Corrective perception, timely diagnosis, and active treatment of this complex disease are critical factors that guarantee a quick recovery of renal function of infants and help them to prevent multiple organ system failure.
METHODS: Thirteen infants with acute renal failure induced by urinary multiple obstruction caused by melamine-containing stones who had been admitted to Beijing Children's Hospital Affiliated to Capital Medical University in 2008 were investigated for the epidemiological characteristics, image features and indications of dialysis. All these infants were treated with dialysis. The efficacy of dialysis was compared with that of two control groups treated with cystoscopic retrograde catheterization into the ureter and medical treatment for the recovery of renal function.
RESULTS: The 13 infants with life-threatening complications treated with dialysis showed a blood urea nitrogen (BUN) level of (30.9+/-7.9) mmol/L and a creatinine (Cr) level of (572+/-173) micromol/L. Of these infants, 8 were treated with peritoneal dialysis (PD), and 5 with hemodialysis (HD). Ten infants recovered to urinate 24-72 hours after dialysis and 3 infants with persistent ureteral obstruction were further treated with cystoscopic retrograde catheterization into the ureter for drainage, and urination resumed soon after the operation. The average time of PD and HD were (2.1+/-0.8) days and (1.2+/-0.4) days, respectively. The total average time of PD and HD dialysis was (1.77+/-0.83) days. The recovery time of renal function of infants after dialysis was (3.08+/-1.20) days, comparable to that of the two control groups treated with catheterization with a cystoscope or by medication. There was no significant difference in the recovery time of renal function among the three groups (P>0.05).
CONCLUSIONS: Melamine-contaminated milk formula may cause urinary stones and obstructive acute renal failure in infants. Dialysis is suggested to treat life-threatening complications such as hyperkalemia, oliguria or anuria if surgical intervention fails. If possible, hemodialysis or peritoneal dialysis can be performed early. Blood purification is feasible to help the infants overcome the critical stage of acute renal failure. Surgical measures can be taken to remove the obstruction if necessary.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19236800

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  4 in total

Review 1.  Melamine-related kidney stones and renal toxicity.

Authors:  Rishikesh P Dalal; David S Goldfarb
Journal:  Nat Rev Nephrol       Date:  2011-03-22       Impact factor: 28.314

2.  Identification of melamine/cyanuric acid-containing nephrolithiasis by infrared spectroscopy.

Authors:  Wen-Chi Chen; San-Yuan Wu; Hsin-Ping Liu; Chiao-Hui Chang; Huey-Yi Chen; Hsin-Yi Chen; Chou-Huang Tsai; Yi-Chun Chang; Fuu-Jen Tsai; Kee-Ming Man; Po-Len Liu; Feng-Yen Lin; Jui-Lung Shen; Wei-Yong Lin; Yung-Hsiang Chen
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

3.  Melamine-induced infant urinary calculi: a report on 24 cases and a 1-year follow-up.

Authors:  Xiangbo Zhang; Jinliang Bai; Pengcheng Ma; Jianhua Ma; Jianghou Wan; Bin Jiang
Journal:  Urol Res       Date:  2010-06-02

4.  Clinical observation of childhood urinary stones induced by melamine-tainted infant formula in Anhui province, China.

Authors:  Peng Hu; Jing Wang; Bo Hu; Ling Lu; Min Zhang
Journal:  Arch Med Sci       Date:  2013-02-21       Impact factor: 3.318

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.